Low thyroid-stimulating hormone as an independent risk factor for Alzheimer disease

Neurology

Volumn 62, Issue 11, 2004, Pages 1967-1971

  Van Osch, Liesbeth A D M ^a   Hogervorst, Eva ^a,b   Combrinck, Marc ^a   Smith, A David ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b RADCLIFFE INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

THYROTROPIN;

AGED; ALZHEIMER DISEASE; ARTICLE; CARDIOVASCULAR RISK; CEREBROVASCULAR DISEASE; CONTROLLED STUDY; EUTHYROIDISM; FEMALE; HORMONE DETERMINATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; THYROTROPIN BLOOD LEVEL;

EID: 2942568408     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.WNL.0000128134.84230.9F     Document Type: Article

References (33)

1. Lopez O, Huff FJ, Martinez AJ, Bedetti CD. Prevalence of thyroid abnormalities is not increased in Alzheimer's disease. Neurobiol Aging 1989;10:247-251.
2. Small GW, Matsuyama SS, Komanduri R, Kumar V, Jarvik LF. Thyroid disease in patients with dementia of the Alzheimer type. J Am Geriatr Soc 1985;33:538-539.
3. Volpato S, Guralnik JM, Fried LP, Remaley AT, Cappola AR, Launer LJ. Serum thyroxine level and cognitive decline in euthyroid older women. Neurology 2002;58:1055-1061.
4. Prinz PN, Scanlan JM, Vitaliano PP, et al. Thyroid hormones: positive relationships with cognition in healthy, euthyroid older men. J Gerontol A Biol Sci Med Sci 1999;54:M111-M116.
5. Luo L, Yano N, Mao Q, Jackson IM, Stopa EG. Thyrotropin releasing hormone (TRH) in the hippocampus of Alzheimer patients. J Alzheimers Dis 2002;4:97-103.
6. Kalmijn S, Mehta KM, Pols HAP, Hofman A, Drexhage HA, Breteler MMB. Subclinical hyperthyroidism and the risk of dementia. The Rotterdam Study. Clin Endocrinol (Oxf) 2000;53:733-737.
7. Ganguli M, Burmeister LA, Seaberg EC, Belle S, DeKosky ST. Association between dementia and elevated TSH: a community-based study. Biol Psychiatry 1996;40:714-725.
8. Christie JE, Whalley LJ, Bennie J, et al. Characteristic plasma hormone changes in Alzheimer's disease. Br J Psychiatry 1987;150:674-681.
9. Hogervorst E, Combrinck M, Smith AD. Low thyroid stimulating hormone in cases with dementia. Neurobiol Aging 2002;23:1128.
10. Toft AD, Boon NA. Thyroid disease and the heart. Heart 2000;84:455-460.
11. Hak AE, Pols HA, Visser TJ, Drexhage HA, Hofman A, Witteman JC. Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: the Rotterdam Study. Ann Intern Med 2000;132:270-278.
12. Biondi B, Palmieri EA, Lombardi G, Fazio S. Effects of subclinical thyroid dysfunction on the heart. Ann Intern Med 2002;137:904-914.
13. Morris MS, Bostom AG, Jacques PF, Selhub J, Rosenberg IH. Hyperhomocysteinemia and hypercholesterolemia associated with hypothyroidism in the Third US National Health and Nutrition Examination Survey. Atherosclerosis 2001;155:195-200.
14. Auer J, Scheibner P, Mische T, Langsteger W, Eber O, Eber B. Subclinical hyperthyroidism as a risk factor for atrial fibrillation. Am Heart J 2001;142:838-842.
15. Osman F, Gammage MD, Franklyn JA. Hyperthyroidism and cardio-vascular morbidity and mortality. Thyroid 2002;12:483-487.
16. Breteler MMB. Vascular risk factors for Alzheimer's disease: an epidemiologic perspective. Neurobiol Aging 2000;21:153-160.
17. Kivipelto M, Helkala EL, Laakso MP, et al. Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study. Br Med J 2001;322:1447-1451.
18. Folstein MF, Folstein S, McHugh PR. Mini-Mental State: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
19. Roth M, Huppert FA, Tym E, Mountjoy CQ. CAMDEX: the Cambridge Examination for Mental Disorders of the Elderly. Cambridge, UK: Cambridge University Press, 1988.
20. McKahnn G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939-944.
21. Mirra SS, Heyman A, McKeel D, et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD), II: standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 1991;41:479-486.
22. Ueland PM, Refsum H, Stabler SP, Malinow MR, Andersson A, Allen RH. Total homocysteine in plasma or serum: methods and clinical applications. Clin Chem 1993;39:1764-1779.
23. Nexo E, Engbaek F, Ueland PM, et al. Evaluation of novel assays in clinical chemistry; qualification of plasma total homocysteine. Clin Chem 2000;46:1150-1156.
24. Wenham PR. Apolipoprotein E genotyping by one-stage PCR. Lancet 1991;337:1158-1159.
25. Gunnarson T, Sjoberg S, Eriksson M, Nordin C. Depressive symptoms in hypothyroid disorder with some observations on biochemical correlates. Neuropsychobiology 2001;43:70-74.
26. Demet MM, Ozmen B, Deveci A, Boyvada S, Adiguzel H, Aydemir O. Depression and anxiety in hyperthyroidism. Arch Med Res 2002;33:552-556.
27. Jorm AF. History of depression as a risk factor for dementia: an updated review. Aust NZ J Psychiatry 2001;35:776-781.
28. Hogervorst E, Barnetson L, Jobst KA, Nagy Z, Combrinck M, Smith AD. Diagnosing dementia: interrater reliability assessment and accuracy of the NINCDS/ADRDA criteria versus CERAD histopathological criteria for Alzheimer's disease. Dement Geriatr Cogn Disord 2000;11:107-113.
29. Ogasawara T, Itoh Y, Tamura M, Ukai Y, Yoshikuni Y, Kimura K. NS-3, a TRH-analog, reverses memory disruption by stimulating cholinergic and noradrenergic systems. Pharmacol Biochem Behav 1996;53:391-399.
30. Giovannini MG, Casamenti F, Nistri A, Paoli F, Pepeu G. Effect of thyrotropin releasing hormone (TRH) on acetylcholine release from different brain areas investigated by microdialysis. Br J Pharmacol 1991;102:363-368.
31. Perry EK. The cholinergic system in old age and Alzheimer's disease. Age Ageing 1980;9:1-8.
32. Chan RS, Huey ED, Maecker HL, et al. Endocrine modulators of necrotic neuron death. Brain Pathol 1996;6:481-491.
33. Bianchi G, Solaroli E, Zaccheroni V, et al. Oxidative stress and antioxidant metabolites in patients with hyperthyroidism: effect of treatment. Horm Metab Res 1999;31:620-624.